Mehak Trehan: Debating the Next Frontier in Hemato-Oncology, BiTEs vs CAR-T
Mehak Trehan/LinkedIn

Mehak Trehan: Debating the Next Frontier in Hemato-Oncology, BiTEs vs CAR-T

Mehak Trehan, Subject Matter Expert at DailyRounds and Marrow, shared on X:

“BiTEs vs CAR-T at MGM Cancer Institute.

Chennai H-CON 2026

20 minutes of debate, an incredible adrenaline rush and an experience I thoroughly enjoyed!

Note to self: Request a stool next time so the audience can actually see the speaker behind the podium!”

More about H-CON 2026

  • MGM H-CON 2026 was held on October 17–18, 2026, at the Radisson Blu Hotel, GST Road, Chennai, bringing together national and international experts in hematology and hemato-oncology.
  • Organized by MGM Cancer Institute, the conference focused on recent advances in hematology, CAR-T cell therapy, and clinical approaches shaping the future of hemato-oncology.
  • Dr. M. A. Raja, Director of Oncology Services and Senior Consultant in Medical Oncology, served as Organising Chairman, while Dr. M. Gopinathan, Consultant in Hemato-Oncology, served as Organising Secretary.
  • The conference provided a platform for scientific exchange, discussion of emerging clinical developments, and collaboration among medical professionals to strengthen knowledge and clinical practice in hemato-oncology.

You may also be interested in:

Legend Biotech Receives FDA IND Clearance for LB2501, a CD19/CD20 In Vivo CAR-T TherapyMehak Trehan: Debating the Next Frontier in Hemato-Oncology, BiTEs vs CAR-T